Patents by Inventor Aarthi Goverdhan

Aarthi Goverdhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGFR-based peptides
    Patent number: 9585938
    Abstract: Observations regarding the role of MUC1 in promoting the nuclear accumulation of EGFR led us to propose the development of peptides to block nuclear accumulation of EGFR as a means to block breast cancer progression. One exemplary peptide, the ENLS1 peptide, promotes cell death in breast cancer cell lines. Studies in the MMTV-pyMT mouse model of breast cancer demonstrate significant anti-tumor activity.
    Type: Grant
    Filed: October 12, 2011
    Date of Patent: March 7, 2017
    Assignee: ARIZONA CANCER THERAPEUTICS, LLC
    Inventors: Joyce A. Schroeder, Benjamin G. Bitler, Aarthi Goverdhan
  • EGFR-BASED PEPTIDES
    Publication number: 20130251727
    Abstract: Observations regarding the role of MUC1 in promoting the nuclear accumulation of EGFR led us to propose the development of peptides to block nuclear accumulation of EGFR as a means to block breast cancer progression. One exemplary peptide, the ENLS1 peptide, promotes cell death in breast cancer cell lines. Studies in the MMTV-pyMT mouse model of breast cancer demonstrate significant anti-tumor activity.
    Type: Application
    Filed: October 12, 2011
    Publication date: September 26, 2013
    Applicant: ARIZONA BIOMEDICAL RESEARCH COMMISSION
    Inventors: Joyce A. Schroeder, Benjamin G. Bitler, Aarthi Goverdhan